Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Dec;30(3):656–660. doi: 10.1128/iai.30.3.656-660.1980

Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.

K Oguma, B Syuto, H Iida, S Kubo
PMCID: PMC551365  PMID: 6785231

Abstract

Antisera against purified type C1 toxin of Clostridium botulinum and its heavy-chain component cross-neutralized type D toxin. Antisera against partially purified type D toxin cross-neutralized type C1 toxin. From the latter serum, a component which neutralized only type D toxin and a component which equally neutralized both C1 and D toxins were obtained. We concluded that the cross-neutralization was not due to the fact that type C and D strains produce both C1 and D toxins but rather to the fact that the toxins have an antigen(s) common to their molecules. The results of the agar gel-double-diffusion test also supported this conclusion.

Full text

PDF
659

Images in this article

658Fig. 1
on p.658
659Fig. 2
on p.659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eklund M. W., Poysky F. T. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol. 1972 Jul;24(1):108–113. doi: 10.1128/am.24.1.108-113.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eklund M. W., Poysky F. T., Reed S. M. Bacteriophage and the toxigenicity of Clostridium botulinum type D. Nat New Biol. 1972 Jan 5;235(53):16–17. doi: 10.1038/newbio235016a0. [DOI] [PubMed] [Google Scholar]
  3. Inoue K., Iida H. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jpn J Med Sci Biol. 1971 Feb;24(1):53–56. [PubMed] [Google Scholar]
  4. Jansen B. C. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J Vet Res. 1971 Jun;38(2):93–98. [PubMed] [Google Scholar]
  5. Kozaki S., Sugii S., Oishi I., Sakaguchi S., Sakaguchi G. Proceedings: Clostridium botulinum type A, B, E and F 12S toxins. Jpn J Med Sci Biol. 1975 Feb;28(1):70–72. [PubMed] [Google Scholar]
  6. Miyazaki S., Iwasaki M., Sakaguchi G. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties. Infect Immun. 1977 Aug;17(2):395–401. doi: 10.1128/iai.17.2.395-401.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Oguma K., Iida H., Shiozaki M., Inoue K. Antigenicity of converting phages obtained from Clostridium botulinum types C and D. Infect Immun. 1976 Mar;13(3):855–860. doi: 10.1128/iai.13.3.855-860.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Oguma K., Iida H., Shiozaki M. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D. Infect Immun. 1976 Sep;14(3):597–602. doi: 10.1128/iai.14.3.597-602.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oguma K., Nakane A., Iida H. Observations on toxin and hemagglutinin produced by Clostridium botulinum type C. Appl Environ Microbiol. 1978 Feb;35(2):462–464. doi: 10.1128/aem.35.2.462-464.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. STERNE M. Hemagglutination by Clostridium botulinum type D. Science. 1954 Apr 2;119(3092):440–441. doi: 10.1126/science.119.3092.440. [DOI] [PubMed] [Google Scholar]
  11. Syuto B., Kubo S. Isolation and molecular size of Clostridium botulinum type C toxin. Appl Environ Microbiol. 1977 Feb;33(2):400–405. doi: 10.1128/aem.33.2.400-405.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol. 1972;26:3–27. doi: 10.1016/s0076-6879(72)26003-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES